Pmgc Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Pmgc Holdings Inc inventory turnover ratio, the Pmgc Holdings Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 3.87 in the second quarter 2026, a new company high. Average inventory processing period, for the Pmgc Holdings Inc in Jun 30 2026 quarter, has decreased to 94 days, compare to 131 days, in the Mar 31 2026 quarter.

Within Healthcare sector 100 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

ELAB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Pmgc Holdings Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ELAB Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-	-	-90.28 %	-86.98 %	-
Y / Y Cost of Sales Growth	-	-	-	-0.36 %	-
Inventory Turnover Ratio (TTM)	3.87	2.78	5.9	0.48	-
ELAB's Total Ranking	#	#	#	#	#
Average inventory processing period	94	131	62	759	-
Seq. Inventory Growth	267.77 %	166.63 %	-25.98 %	-	-
Seq. Cost of Sales Growth	72895.19 %	-99.28 %	47.9 %	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 19
Healthcare Sector	# 101
Overall Market	#

Inventory Turnover Ratio Statistics
High	Average	Low
3.87	2.23	0.48
(Jun 30 2026)		(Dec 31 2024)

ELAB Company Profile >> Back to ELAB Efficiency Comparisons >> Compare ELAB Inventory Turnover Ratio to its Competitors

Financial Statements
Pmgc Holdings Inc 's Inventories	$ 1 Millions	Visit ELAB's Balance sheet
Pmgc Holdings Inc 's Cost of Revenues TTM	$ 1 Millions	Visit ELAB's Income Statement
What are ELAB's Sales?		Visit ELAB's Sales by Segment

Other Inventory Turnover Ratios
Pmgc Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELAB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELAB's Competitors
Inventory Turnover Ratio for ELAB's Suppliers
Inventory Turnover Ratio for ELAB's Customers

You may also want to know
ELAB's Sales Growth Rates	ELAB's Pe Price to earnings ratio	ELAB's Receivables Turnover Ratio	ELAB's Stock Quote
ELAB's Net Income Growth Rates	ELAB's Ps Price to Sales ratio	ELAB's Sales per Employee	ELAB's Asset Turnover Ratio
ELAB's Net Margin	ELAB's Pb Price to Book ratio	ELAB's Financial Strength Ratios	ELAB's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Revvity Inc	2.98	$ 1,136.473 Millions	$ 381 Millions
Amneal Pharmaceuticals Inc	2.98	$ 1,891.689 Millions	$ 635 Millions
Resmed Inc	2.97	$ 2,770.562 Millions	$ 933 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions

Date modified: 2026-08-21T17:26:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.